| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |